强生宣布顺利完成消费者健康业务的分拆

美通社2023-08-24

美国新泽西州新不伦瑞克 2023年8月24日 /PRNewswire/ -- 2023年8月23日，强生公司正式宣布了顺利完成分拆Johnson & Johnson 和 Kenvue 的换股要约。即日起，Kenvue将完全独立运营。两家公司将继续履行其独特的使命，为全球的病患和消费者提供创新的医疗健康产品和消费者健康产品，推动人类健康事业砥砺前行。公司宣布了先前向股东提出的换股要约的最终结果，即...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2361952333?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2023-08-24 20:05","share_image_url":"https://static.laohu8.com/7d5258e5fa9d58069a293859983c0a71","id":"2361952333","market":"us","top_or_hot":-1,"title":"强生宣布顺利完成消费者健康业务的分拆","media":"美通社","content":"<div>\n<p>美国新泽西州新不伦瑞克 2023年8月24日 /PRNewswire/ -- 2023年8月23日，强生公司正式宣布了顺利完成分拆Johnson & Johnson 和 Kenvue 的换股要约。即日起，Kenvue将完全独立运营。两家公司将继续履行其独特的使命，为全球的病患和消费者提供创新的医疗健康产品和消费者健康产品，推动人类健康事业砥砺前行。 公司宣布了先前向股东提出的换股要约的最终结果，即...</p>\n\n<a href=\"https://wwwold.prnasia.com/story/archive/4192295_ZH92295_1\">网页链接</a>\n\n</div>\n","source":"prnasia","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>强生宣布顺利完成消费者健康业务的分拆</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n强生宣布顺利完成消费者健康业务的分拆\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-08-24 20:05 北京时间&nbsp;&nbsp;&nbsp;<a href=https://wwwold.prnasia.com/story/archive/4192295_ZH92295_1><strong>美通社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>美国新泽西州新不伦瑞克 2023年8月24日 /PRNewswire/ -- 2023年8月23日，强生公司正式宣布了顺利完成分拆Johnson & Johnson 和 Kenvue 的换股要约。即日起，Kenvue将完全独立运营。两家公司将继续履行其独特的使命，为全球的病患和消费者提供创新的医疗健康产品和消费者健康产品，推动人类健康事业砥砺前行。 公司宣布了先前向股东提出的换股要约的最终结果，即...</p>\n\n<a href=\"https://wwwold.prnasia.com/story/archive/4192295_ZH92295_1\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4534","symbol_name":"瑞士信贷持仓","start_time":0,"source_url":"https://wwwold.prnasia.com/story/archive/4192295_ZH92295_1","article_id":"2361952333","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2361952333","pubTimestamp":1692878700,"columns":[],"sourceInfo":{"source_id":"prnasia","name":"美通社"},"weMediaInfo":null,"summary":"美国新泽西州新不伦瑞克2023年8月24日 /PRNewswire/ -- 2023年8月23日，强生公司正式宣布了顺利完成分拆Johnson & Johnson 和 Kenvue 的换股要约。根据要约，强生公司已接受190,955,436股强生公司普通股，以交换获得1,533,830,450股Kenvue普通股。由于换股要约获得超额认购，基于投标股数量，强生公司仅按比例接受了有效投标但未被有效撤回的强生公司普通股的一部分。换股要约完成后，强生公司将继续持有占Kenvue普通股总量约9.5%的股份。","collect":0,"end_time":0,"defaultTopTitle":"prnasia.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","LU1074936037.SGD":"JPMorgan Funds - US Value A (acc) SGD","LU0792757196.USD":"TEMPLETON SHARIAH GLOBAL EQUITY FUND \"A\" (USD) ACC","LU1732800096.USD":"摩根大通环球收益基金A (irc)","BK4533":"AQR资本管理(全球第二大对冲基金)","JNJ":"强生","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","BK4592":"伊斯兰概念","SG9999002232.USD":"Allianz Global High Payout USD","BK4504":"桥水持仓","BK4559":"巴菲特持仓","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","BK4588":"碎股","SG9999002224.SGD":"Allianz Global High Payout SGD","LU0795875086.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","BK4183":"个人用品","BK4550":"红杉资本持仓","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","LU2347655156.SGD":"JPMorgan Investment Funds - Global Income A (icdiv) SGD-H","LU1244550494.USD":"FRANKLIN GLOBAL MULTI-ASSET INCOME \"A\" (USDHEDGED) ACC","BK4007":"制药","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","LU0882574055.USD":"富达全球健康医疗A ACC","LU1032466523.USD":"高盛全球多资产收益组合Acc","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","LU1261432733.SGD":"Fidelity World A-ACC-SGD","BK4581":"高盛持仓","BK4532":"文艺复兴科技持仓","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME  \"AA\" (SGDHDG) INC","LU0234572021.USD":"高盛美国核心股票组合Acc","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","KVUE":"Kenvue Inc"},"translate_title":"Johnson & Johnson announced the successful completion of the spin-off of consumer health business","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":1,"KVUE":0.9},"content_text":"美国新泽西州新不伦瑞克 2023年8月24日 /PRNewswire/ -- 2023年8月23日，强生公司正式宣布了顺利完成分拆Johnson & Johnson 和 Kenvue 的换股要约。即日起，Kenvue将完全独立运营。两家公司将继续履行其独特的使命，为全球的病患和消费者提供创新的医疗健康产品和消费者健康产品，推动人类健康事业砥砺前行。 公司宣布了先前向股东提出的换股要约的最终结果，即允许股东将其持有的强生公司普通股换为由强生公司所持有的Kenvue（纽约证券交易所：KVUE）普通股。该换股要约于2023年8月18日当地时间午夜12时结束。根据要约，强生公司已接受190,955,436股强生公司普通股，以交换获得1,533,830,450股Kenvue普通股。 由于换股要约获得超额认购，基于投标股数量，强生公司仅按比例接受了有效投标但未被有效撤回的强生公司普通股的一部分。根据要约条款，持有少于100股强生公司普通股的股东，即\"零头股\"股东，如有效投标其所有股份，则不受比例限制。所有符合\"零头股\"条件的股东有效投标的股份均获得接受。最终比例为23.231832%，适用于其他所有有效投标的强生公司普通股，以确定获得接受的股份数量。换股要约完成后，强生公司将继续持有占Kenvue普通股总量约9.5%的股份。 强生公司董事会主席兼首席执行官杜安卿表示：\"强生公司专注于具有变革性的制药和医疗科技解决方案，这一无可比拟的独特优势推动我们在医疗健康领域不断创新。我们为这一历史性的里程碑付出的巨大努力深感自豪，这为股东带来重要价值的同时，也使强生公司更加灵活、专注和富有竞争力。\"","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2361952333","isCrawlerRequest":true}